Here is the latest stock price and chart of Biocon. For more details, see the Biocon company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Revealed: 3 Stocks for Potentially Massive Gains
Live BSE Quotes | Apr 13, 2021 (Close) | ||
---|---|---|---|
Price (Rs)406.90 | Open (Rs) 404.00 | High (Rs) 412.10 | Low (Rs) 401.55 |
% Change0.69 | Volume 144,799 | Value (Rs) 58,888,531 | 52-Week H/L 487.70 / 320.90 |
Live NSE Quotes | Apr 13, 2021 (Close) | ||
---|---|---|---|
Price (Rs)406.95 | Open (Rs) 406.70 | High (Rs) 412.35 | Low (Rs) 401.35 |
% Change0.66 | Volume 2,068,043 | Value (Rs) 842,247,950 | 52-Week H/L 487.75 / 320.70 |
Change | |||||
---|---|---|---|---|---|
1 Day 0.69% | 1 Month 2.84% | 3 Months -12.12% | 1 Year 19.54% | 5 Years (CAGR)* 34.52% | 10 Years (CAGR)* 20.67% |
* Compound Annual Growth Rate
Valuation | |||
---|---|---|---|
EPS (Rs)* 12.11 | P/E Ratio (x) 33.60 | Market Cap (Rs m) 244,140.00 | P/BV (x) 4.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX ![]() |
||||||
PERIOD |
BIOCON last traded price was up 0.7% to Rs 406.9 on the BSE. On the NSE, BIOCON last traded price was up 0.7% to Rs 407.0. The total volume of shares traded was 2.2 m.
Overall, the broader S&P BSE HEALTHCARE Index was down by 0.7%. And the benchmark S&P BSE SENSEX was at 48,544.1 (up 1.4%).
Over the last 30 days, the BIOCON share price is up 1.6%. And over the last one year, BIOCON share price is up 19.5%.
What else is happening in the markets today? Dig in...
Indian share markets witnessed most of the buying interest during closing hours today and ended on a strong note.
For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.
More Views on NewsRather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
What should you do if the market falls? In this video, I'll tell you what I will do.
A favourable demand supply scenario makes a strong case for real estate prices.
Ajit Dayal on how India's vaccine strategy will impact the markets.
Rahul Shah on whether Bharti Airtel will emerge as the next big thing in the Indian stock market
More